These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34569452)

  • 21. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors.
    Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L
    Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.
    Jena NR
    J Mol Model; 2012 Feb; 18(2):631-44. PubMed ID: 21559963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells.
    Lee YI; Seo M; Kim Y; Kim SY; Kang UG; Kim YS; Juhnn YS
    J Biol Chem; 2005 Jun; 280(23):22044-52. PubMed ID: 15799972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease.
    Guardigni M; Pruccoli L; Santini A; Simone A; Bersani M; Spyrakis F; Frabetti F; Uliassi E; Andrisano V; Pagliarani B; Fernández-Gómez P; Palomo V; Bolognesi ML; Tarozzi A; Milelli A
    ACS Chem Neurosci; 2023 Jun; 14(11):1963-1970. PubMed ID: 37218653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity.
    Lin CH; Hsieh YS; Sun YC; Huang WH; Chen SL; Weng ZK; Lin TH; Wu YR; Chang KH; Huang HJ; Lee GC; Hsieh-Li HM; Lee-Chen GJ
    Biomol Ther (Seoul); 2023 Jan; 31(1):127-138. PubMed ID: 35790892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells.
    Kim Y; Lee YI; Seo M; Kim SY; Lee JE; Youn HD; Kim YS; Juhnn YS
    J Neurochem; 2009 Oct; 111(2):344-54. PubMed ID: 19659461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
    Xiong Z; Hongmei Z; Lu S; Yu L
    Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
    Arfeen M; Patel R; Khan T; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
    Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
    Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
    J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural compound screening predicts novel GSK-3 isoform-specific inhibitors.
    Ahmad F; Gupta A; Marzook H; Woodgett JR; Saleh MA; Qaisar R
    Biochimie; 2024 Oct; 225():68-80. PubMed ID: 38723940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.
    Unal G; Dokumaci AH; Ozkartal CS; Yerer MB; Aricioglu F
    Chem Biol Interact; 2019 Dec; 314():108823. PubMed ID: 31563592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular docking study of GSK-3β interaction with nomilin, kihadanin B, and related limonoids and triterpenes with a furyl-δ-lactone core.
    Vergoten G; Bailly C
    J Biochem Mol Toxicol; 2022 Sep; 36(9):e23130. PubMed ID: 35686814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
    Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
    Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
    Bahmad HF; Chalhoub RM; Harati H; Bou-Gharios J; Assi S; Ballout F; Monzer A; Msheik H; Araji T; Elajami MK; Ghanem P; Chamaa F; Kadara H; Abou-Antoun T; Daoud G; Fares Y; Abou-Kheir W
    Pharmacol Rep; 2021 Feb; 73(1):211-226. PubMed ID: 33030673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the anti-cancer potential of epoxyazadiradione in neuroblastoma: experimental assays and molecular analysis.
    Chandel S; Bhattacharya A; Gautam A; Zeng W; Alka O; Sachsenberg T; Gupta GD; Narang RK; Ravichandiran V; Singh R
    J Biomol Struct Dyn; 2023 Sep; ():1-19. PubMed ID: 37753734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.